Outcomes of Salvage Robotic-assisted Radical Prostatectomy in the last decade: systematic review and perspectives of referral centers
Int. braz. j. urol
; 49(6): 677-687, Nov.-Dec. 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| LILACS
| ID: biblio-1550288
Biblioteca responsável:
BR1.1
ABSTRACT
ABSTRACT Purpose:
Salvage robotic-assisted radical prostatectomy (S-RARP) has gained prominence in recent years for treating patients with cancer recurrence following non-surgical treatments of Prostate Cancer. We conducted a systematic literature review to evaluate the role and outcomes of S-RARP over the past decade. Materials andMethods:
A systematic review was conducted, encompassing articles published between January 1st, 2013, and June 1st, 2023, on S-RARP outcomes. Articles were screened according to PRISMA guidelines, resulting in 33 selected studies. Data were extracted, including patient demographics, operative times, complications, functional outcomes, and oncological outcomes.Results:
Among 1,630 patients from 33 studies, radiotherapy was the most common primary treatment (42%). Operative times ranged from 110 to 303 minutes, with estimated blood loss between 50 to 745 mL. Intraoperative complications occurred in 0 to 9% of cases, while postoperative complications ranged from 0 to 90% (Clavien 1-5). Continence rates varied (from 0 to 100%), and potency rates ranged from 0 to 66.7%. Positive surgical margins were reported up to 65.6%, and biochemical recurrence ranged from 0 to 57%.Conclusion:
Salvage robotic-assisted radical prostatectomy in patients with cancer recurrence after previous prostate cancer treatment is safe and feasible. The literature is based on retrospective studies with inherent limitations describing low rates of intraoperative complications and small blood loss. However, potency and continence rates are largely reduced compared to the primary RARP series, despite the type of the primary treatment. Better-designed studies to assess the long-term outcomes and individually specify each primary therapy impact on the salvage treatment are still needed. Future articles should be more specific and provide more details regarding the previous therapies and S-RARP surgical techniques.
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
LILACS
Idioma:
Inglês
Revista:
Int. braz. j. urol
Assunto da revista:
Urologia
Ano de publicação:
2023
Tipo de documento:
Artigo
País de afiliação:
Bélgica
/
Alemanha
/
Itália
/
Romênia
/
Espanha
/
Suíça
/
Estados Unidos
/
Reino Unido
Instituição/País de afiliação:
ASST Grande Ospedale Metropolitano Niguarda/IT
/
AdventHealth Global Robotics Institute/US
/
Autonoma University of Barcelona at Fundacio Puigvert/ES
/
Iuliu Hatieganu University of Medicine and Pharmacy/RO
/
La Statale University/IT
/
Luzerner Kantonsspital/CH
/
ORSI Academy/BE
/
San Raffaele Hospital/IT
/
The Royal Marsden NHS Foundation Trust/GB
/
University Hospital Frankfurt/DE